19:11:28 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-03-07 Kvartalsrapport 2024-Q2
2023-11-17 Ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 Årsstämma 2024
2023-09-28 Bokslutskommuniké 2023
2023-04-24 Extra Bolagsstämma 2023
2023-03-23 Kvartalsrapport 2023-Q2
2022-11-17 Årsstämma 2023
2022-10-25 Ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 Bokslutskommuniké 2022
2022-06-29 Extra Bolagsstämma 2022
2022-02-24 Kvartalsrapport 2022-Q2
2021-10-29 Ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 Årsstämma 2022
2021-09-15 Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2021-03-25 08:30:00

Nightingale Health Plc - Managers' transactions - 25 March 2021 9:30 a.m. (Finnish time)

Nightingale Health Plc - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 743700WUIPC24LVMLO66_20210324144018_2

____________________________________________

Transaction date: 2021-03-24

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 4 Unit price: 5.68 EUR

(2): Volume: 754 Unit price: 5.68 EUR

(3): Volume: 444 Unit price: 5.66 EUR

(4): Volume: 41 Unit price: 5.7 EUR

(5): Volume: 415 Unit price: 5.7 EUR

(6): Volume: 100 Unit price: 5.7 EUR

(7): Volume: 500 Unit price: 5.68 EUR

(8): Volume: 581 Unit price: 5.72 EUR

(9): Volume: 100 Unit price: 5.7 EUR

(10): Volume: 146 Unit price: 5.74 EUR

(11): Volume: 331 Unit price: 5.74 EUR

(12): Volume: 174 Unit price: 5.74 EUR

(13): Volume: 430 Unit price: 5.6 EUR

(14): Volume: 368 Unit price: 5.6 EUR

(15): Volume: 151 Unit price: 5.58 EUR

(16): Volume: 255 Unit price: 5.6 EUR

(17): Volume: 200 Unit price: 5.58 EUR

(18): Volume: 458 Unit price: 5.5 EUR

(19): Volume: 458 Unit price: 5.5 EUR

(20): Volume: 447 Unit price: 5.5 EUR

(21): Volume: 530 Unit price: 5.5 EUR

(22): Volume: 411 Unit price: 5.46 EUR

(23): Volume: 10 Unit price: 5.44 EUR

(24): Volume: 50 Unit price: 5.44 EUR

(25): Volume: 310 Unit price: 5.46 EUR

(26): Volume: 169 Unit price: 5.5 EUR

(27): Volume: 292 Unit price: 5.5 EUR

(28): Volume: 505 Unit price: 5.54 EUR

(29): Volume: 266 Unit price: 5.5 EUR

(30): Volume: 100 Unit price: 5.5 EUR

Aggregated transactions

(30): Volume: 9,000 Volume weighted average price: 5.59265 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com,tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.